Sun Pharma reports net profit of Rs. 4,541-crore for FY2014-15

摘要

In the year that saw Sun Pharmaceutical merge Ranbaxy into one entity, the company clocked consolidated net sales of Rs. 27,286-crore, and a net profit of Rs. 4,541-crore for the year ended March 31, 2015. The company's last quarter performance saw a net profit at Rs. 888-crore in the quarter ended March 31, 2015, and net sales of Rs. 6,145-crore. The performance for the year and quarter under review were not comparable to the previous year because of the Ranbaxy deal getting sealed.